L'intérêt à découvert pour Cannara Biotech donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Cannara Biotech. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Cannara Biotech (OTC:LOVFF) Stock, Rapport sur les intérêts à découvert

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

CANNARA BIOTECH INC by Cannara Biotech Inc.

Cannara Biotech Inc

Trading Ideas

ARQQ

Arqit Quantum Shares Halted To The Downside; Stock Now Down -12.78%

U.S. stocks were lower, with the Dow Jones index falling more than 300 points on Friday.
Shares of Amedisys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMED#NASDAQ">AMED</a>) rose sharply <a href="https://www.benzinga.com/quote/AMED/news">during Friday's session</a>.
Amedisys-UnitedHealth announced in filing earlier, they extended merger deadline until Dec. 31, 2025.
Amedisys shares gained 4.2% to $89.51 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Quantum-Si incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) shares surged 47% to $3.1596.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 43.7% to $2.0397.</li>
<li>Quantum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) shares surged 19.5% to $79.99.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) gained 19.4% to $12.18.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares rose 16.6% to $17.99. Shares of quantum computing companies traded higher. The sector has recently seen increased interest.</li>
<li>Solid Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) shares gained 15.9% to $2.2607.</li>
<li>Intchains Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares rose 14.7% to $7.00.</li>
<li>Grid Dynamics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDYN#NASDAQ">GDYN</a>) shares gained 14.4% to $24.11.</li>
<li>Atomera Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOM#NASDAQ">ATOM</a>) rose 11.3% to $14.01.</li>
<li>Alliance Entertainment Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AENT#NASDAQ">AENT</a>) gained 7.8% to $8.41.</li>
<li>IperionX Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPX#NASDAQ">IPX</a>) surged 7.6% to $34.01.</li>
<li>Lamb Weston Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) rose 3% to $67.23.</li>
<li>Lotus Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOT#NASDAQ">LOT</a>) rose 4% to $4.2450.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42699617/top-3-tech-and-telecom-stocks-that-may-rocket-higher-in-q4">Top 3 Tech And Telecom Stocks That May Rocket Higher In Q4</a></li>
</ul>

AENT

AMED

ATOM

GDYN

QMCO

RGTI

SLDP

Amedisys, Rigetti Computing And Other Big Stocks Moving Higher On Friday

Abpro Holdings Shares Halted To The Downside; Stock Now Up 44.85%

Financial giants have made a conspicuous bullish move on ASML Holding. Our analysis of options history for ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) revealed 11 unusual trades.
Delving into the details, we found 54% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $341,834, and 8 were calls, valued at $385,800.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $640.0 to $900.0 for ASML Holding during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ASML Holding's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ASML Holding's substantial trades, within a strike price spectrum from $640.0 to $900.0 over the preceding 30 days.
<h3>ASML Holding 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735312542_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$189.7</td>
<td>$188.1</td>
<td>$188.1</td>
<td>$900.00</td>
<td>$263.3K</td>
<td align="right">170</td>
<td align="right">14</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$90.8</td>
<td>$88.2</td>
<td>$89.5</td>
<td>$700.00</td>
<td>$89.5K</td>
<td align="right">133</td>
<td align="right">10</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$212.0</td>
<td>$210.0</td>
<td>$212.0</td>
<td>$640.00</td>
<td>$63.6K</td>
<td align="right">6</td>
<td align="right">3</td>
</tr>
<tr>
<td>ASML</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$56.7</td>
<td>$56.2</td>
<td>$56.2</td>
<td>$710.00</td>
<td>$56.2K</td>
<td align="right">90</td>
<td align="right">12</td>
</tr>
<tr>
<td>ASML</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$153.3</td>
<td>$146.0</td>
<td>$148.5</td>
<td>$860.00</td>
<td>$44.5K</td>
<td align="right">26</td>
<td align="right">3</td>
</tr>
</tbody>
</table>

<h3>About ASML Holding</h3>
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.
Having examined the options trading patterns of ASML Holding, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is ASML Holding Standing Right Now?</h3>
<ul>
<li>With a volume of 161,794, the price of ASML is down -0.22% at $714.25. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 33 days.</li>
</ul>
<h3>Professional Analyst Ratings for ASML Holding</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $767.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Bernstein continues to hold a Outperform rating for ASML Holding, targeting a price of $767. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ASML Holding, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

ASML

What the Options Market Tells Us About ASML Holding

Investors with a lot of money to spend have taken a bearish stance on Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CRM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 16 uncommon options trades for Salesforce.
This isn't normal.
The overall sentiment of these big-money traders is split between 18% bullish and 75%, bearish.
Out of all of the special options we uncovered, 14 are puts, for a total amount of $800,252, and 2 are calls, for a total amount of $78,016.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $270.0 to $450.0 for Salesforce over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Salesforce options trades today is 916.89 with a total volume of 1,968.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Salesforce's big money trades within a strike price range of $270.0 to $450.0 over the last 30 days.
<h3>Salesforce 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735312537_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$23.65</td>
<td>$23.4</td>
<td>$23.65</td>
<td>$360.00</td>
<td>$115.8K</td>
<td>2.0K</td>
<td align="right">304</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$21.3</td>
<td>$20.45</td>
<td>$21.3</td>
<td>$360.00</td>
<td>$100.1K</td>
<td>2.0K</td>
<td align="right">2</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$17.15</td>
<td>$16.65</td>
<td>$17.15</td>
<td>$330.00</td>
<td>$90.8K</td>
<td>656</td>
<td align="right">101</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/10/25</td>
<td>$9.5</td>
<td>$8.95</td>
<td>$9.05</td>
<td>$342.50</td>
<td>$81.4K</td>
<td>7</td>
<td align="right">96</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$6.55</td>
<td>$6.4</td>
<td>$6.55</td>
<td>$337.50</td>
<td>$58.9K</td>
<td>14</td>
<td align="right">100</td>
</tr>
</tbody>
</table>

<h3>About Salesforce</h3>
Salesforce provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
After a thorough review of the options trading surrounding Salesforce, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Salesforce's Current Market Status</h3>
<ul>
<li>With a volume of 425,816, the price of CRM is down -0.55% at $339.82. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 61 days.</li>
</ul>
<h3>Professional Analyst Ratings for Salesforce</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $414.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from JMP Securities lowers its rating to Market Outperform with a new price target of $450. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Salesforce with a target price of $425. 
&#x2A; An analyst from Truist Securities downgraded its action to Buy with a price target of $400. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on Salesforce, maintaining a target price of $390. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Salesforce, targeting a price of $405. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Salesforce, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

What the Options Market Tells Us About Salesforce

Whales with a lot of money to spend have taken a noticeably bearish stance on Oklo.
Looking at options history for Oklo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 6% of the investors opened trades with bullish expectations and 73% with bearish.
From the overall spotted trades, 9 are puts, for a total amount of $1,376,381 and 6, calls, for a total amount of $263,250.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $15.0 and $22.5 for Oklo, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Oklo's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Oklo's substantial trades, within a strike price spectrum from $15.0 to $22.5 over the preceding 30 days.
<h3>Oklo Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735312532_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.9</td>
<td>$0.8</td>
<td>$1.5</td>
<td>$20.00</td>
<td>$390.9K</td>
<td>2.0K</td>
<td>3.4K</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.2</td>
<td>$2.15</td>
<td>$2.15</td>
<td>$22.00</td>
<td>$191.9K</td>
<td>63</td>
<td>1.3K</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$2.3</td>
<td>$2.05</td>
<td>$2.2</td>
<td>$22.00</td>
<td>$188.7K</td>
<td>63</td>
<td>2.2K</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.35</td>
<td>$2.15</td>
<td>$2.35</td>
<td>$22.00</td>
<td>$125.2K</td>
<td>63</td>
<td>5.0K</td>
</tr>
<tr>
<td>OKLO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.6</td>
<td>$1.55</td>
<td>$1.55</td>
<td>$20.00</td>
<td>$116.1K</td>
<td>2.0K</td>
<td>4.5K</td>
</tr>
</tbody>
</table>

<h3>About Oklo</h3>
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.
<h3>Where Is Oklo Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,849,750, the price of OKLO is down by -5.49%, reaching $22.72.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 48 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Oklo</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $26.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Wedbush downgraded its rating to Outperform, setting a price target of $26. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Oklo options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

OKLO

Oklo's Options Frenzy: What You Need to Know

HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) has outperformed the market over the past 5 years by 2.28% on an annualized basis producing an average annual return of 15.43%. Currently, HCA Healthcare has a market capitalization of $78.13 billion. 
Buying $100 In HCA: If an investor had bought $100 of HCA stock 5 years ago, it would be worth $205.31 today based on a price of $302.76 for HCA at the time of writing.
<h3>HCA Healthcare's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1735312508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

$100 Invested In HCA Healthcare 5 Years Ago Would Be Worth This Much Today

WIIM

Amedisys shares are trading higher after the company announced it extended its merger deadline with UnitedHealth.

Offerings

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

Inspira Technologies Announces $3.2M Private Placement With Sale Of 4.61M Shares And Warrants Priced At $0.70; Warrants Carry $1.10 Exercise Price And 18-Month Term, Proceeds To Fund Working Capital And Corporate Purposes

Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) has hit a technical snag — its stock just made <a href="https://www.benzinga.com/topic/death-cross">a Death Cross</a>. This bearish signal occurs when a stock&#8217;s 50-day moving average dips below its 200-day moving average.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="813" height="552" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27083351/UBER-Death-Cross.jpg" alt="" class="wp-image-709283" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27083351/UBER-Death-Cross.jpg 813w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27083351/UBER-Death-Cross-300x204.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/27083351/UBER-Death-Cross-768x521.jpg 768w" sizes="(max-width: 813px) 100vw, 813px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122724&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
For Uber, the current price action reflects a significant shift, but is this trend here to stay?
Read Also: <a href="https://www.benzinga.com/24/12/42656752/5-tech-stocks-to-buy-as-ai-hype-fizzles">5 Tech Stocks to Buy as AI Hype Fizzles</a>
<h1 class="wp-block-heading">Uber Stock Chart: Bearish Signals Drive The Trend</h1>
Uber&#8217;s stock price of $61.56 has fallen below its 20-, 50- and 200-day simple moving averages, with a (moving average convergence/divergence) MACD indicator at a negative 2.73 and an RSI of 35.66 — hovering near oversold territory.
These signals confirm selling pressure and a bearish momentum. Yet, the eight-day SMA of $61.24 offers a sliver of bullish hope, signaling a potential short-term rebound.
<h1 class="wp-block-heading">Jim Cramer's Contrarian Take</h1>
Jim Cramer, a notable market commentator, recently <a href="https://www.insidermonkey.com/blog/jim-cramer-on-uber-technologies-inc-uber-i-think-that-ubers-attractive-and-its-come-down-a-lot-and-i-do-like-it-1414305/">weighed</a> in on Uber's slump. "It's discouraging&#8230; but I think Uber is attractive. It's come down a lot, and I like it," he said. 
His bullish stance underscores a belief in Uber&#8217;s fundamentals, even as technical signals wave red flags.
<h1 class="wp-block-heading">Regulatory Roadblocks, Market Challenges</h1>
Adding to Uber&#8217;s woes, Taiwan's Fair Trade Commission <a href="https://www.benzinga.com/markets/equities/24/12/42678877/ubers-foodpanda-acquisition-blocked-in-taiwan-due-to-competition-concerns">blocked its $950 million acquisition</a> of Foodpanda over antitrust concerns. 
This setback prevents Uber from consolidating its food delivery dominance in the region. The FTC decision reflects the regulatory hurdles the company faces globally, complicating its growth strategy.
<h1 class="wp-block-heading">What Lies Ahead For Uber Stock?</h1>
Despite these challenges, Uber remains a dominant player in ride-sharing and food delivery, sectors poised for recovery in 2025. The company's diverse revenue streams and strong brand give it resilience, but the path forward demands innovation and strategic recalibration.
Uber&#8217;s Death Cross highlights significant near-term risks, but it's not all doom and gloom. 
For investors, the current bearish trend might present a buying opportunity, particularly if the stock shows signs of stabilization. With its global footprint and adaptability, Uber could still turn this ride around — though for now, the road looks bumpy.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/small-cap/24/12/42700917/3-russell-2000-tech-stocks-skyrocketed-1000-more-2024-analysts-getting-started">3 Russell 2000 Tech Stocks That Skyrocketed 1,000% Or More In 2024: Analysts Say They&#8217;re Just Getting Started</a></li>
</ul>
Photo: Shutterstock

Technicals

Travel

General

UBER

Uber's Death Cross: Chart Looks 'Terrible,' Yet Jim Cramer Sees Opportunity

VRAR

The Glimpse Group Shares Resume Trade

U.S. stocks traded lower this morning, with the Nasdaq Composite dipping over 1% on Friday.
The Dow traded down 0.37% to 43,165.19 while the NASDAQ fell 1.37% to 19,745.08. The S&amp;P 500 also fell, dropping, 0.80% to 5,989.46.
Check This Out: <a href="https://www.benzinga.com/24/12/42700097/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks With Over 7% Dividend Yields</a>
Leading and Lagging Sectors Energy shares rose by 0.9% on Friday.
In trading on Friday, information technology shares dipped by 1.3%.
Top Headline
The U.S. trade deficit in goods increased to $102.86 billion in November, from a revised gap of $98.3 billion in the previous month and versus market estimates of a $100.7 billion deficit.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) shares shot up 255% to $0.5725. iLearningEngines recently announced it voluntarily filed for Chapter 11 Bankruptcy.</li>
<li>Shares of Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>)got a boost, surging 253% to $1.5904.</li>
<li>Ambow Education Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#NASDAQ">AMBO</a>) shares were also up, gaining 72% to $3.8532.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Millennium Group International Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGIH#NASDAQ">MGIH</a>) shares dropped 29% to $2.1179.</li>
<li>Shares of reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) were down 22% to $2.78.</li>
<li>Gaxos.ai Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GXAI#NASDAQ">GXAI</a>) was down, falling 23% to $2.7600. Gaxos.ai announced $4 million registered direct offering priced at-the-market under Nasdaq rules.</li>
</ul>
Commodities In commodity news, oil traded up 1.3% to $70.49 while gold traded down 0.9% at $2,630.90.
Silver traded down 1% to $30.100 on Friday, while copper rose 0.1% to $4.1305.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.4%, Germany's DAX gained 0.5% and France's CAC 40 rose 0.7%. Spain's IBEX 35 Index rose 0.2%, while London's FTSE 100 rose 0.1%.
Asia Pacific Markets
Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 1.80%, China's Shanghai Composite Index gaining 0.06%, Hong Kong's Hang Seng Index falling 0.04% and India's BSE Sensex gaining 0.29%.
Economics
<ul>
<li>U.S. wholesale inventories declined by 0.2% month-over-month to $902 billion in November compared to a revised 0.1% gain in the previous month and versus market estimates of a 0.2% increase.</li>
<li>The U.S. trade deficit in goods increased to $102.86 billion in November, from a revised gap of $98.3 billion in the previous month and versus market estimates of a $100.7 billion deficit.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42699617/top-3-tech-and-telecom-stocks-that-may-rocket-higher-in-q4">Top 3 Tech And Telecom Stocks That May Rocket Higher In Q4</a></li>
</ul>

Eurozone

Commodities

Intraday Update

AILE

AIRE

AMBO

GXAI

INTZ

MGIH

US Stocks Open Lower, Nasdaq Down Over 1%

LAES

SEALSQ Shares Halted To The Downside; Stock Now Up 2.40%

On December 26, a recent SEC filing unveiled that Donald T. Gardner III, Chief Financial Officer at Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) made an insider sell.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000055529/000177505224000006//Archives/edgar/data/55529/000177505224000006/0001775052-24-000006-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that III sold 2,049 shares of Kewaunee Scientific. The total transaction amounted to $119,236. 
Tracking the Friday's morning session, Kewaunee Scientific shares are trading at $60.3, showing a down of 5.22%.
<h3>Get to Know Kewaunee Scientific Better</h3>
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
<h3>Understanding the Numbers: Kewaunee Scientific's Finances</h3>
Revenue Challenges: Kewaunee Scientific's revenue growth over 3 months faced difficulties. As of 31 October, 2024, the company experienced a decline of approximately -5.3%. This indicates a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 29.21%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 1.05, Kewaunee Scientific showcases strong earnings per share.
</li>
</ul>
Debt Management: Kewaunee Scientific's debt-to-equity ratio is below the industry average at 0.14, reflecting a lower dependency on debt financing and a more conservative financial approach.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: Kewaunee Scientific's P/E ratio of 10.03 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.95 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Kewaunee Scientific's EV/EBITDA ratio at 10.06 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000055529">Check Out The Full List Of Kewaunee Scientific's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

KEQU

Insider Transaction: Donald T. Gardner III Sells $119K Worth Of Kewaunee Scientific Shares

Making a noteworthy insider sell on December 26, Randall K Fields, Chief Executive Officer at ReposiTrak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRAK#NYSE">TRAK</a>), is reported in the latest SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000050471/000141588924030148//Archives/edgar/data/50471/000141588924030148/0001415889-24-030148-index.htm">U.S. Securities and Exchange Commission</a> on Thursday outlined that Fields executed a sale of 7,500 shares of ReposiTrak with a total value of $165,793.
As of Friday morning, ReposiTrak shares are up by 1.72%, currently priced at $23.11.
<h3>Discovering ReposiTrak: A Closer Look</h3>
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
<h3>Breaking Down ReposiTrak's Financial Performance</h3>
Revenue Growth: ReposiTrak's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 7.53%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 84.21%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, ReposiTrak exhibits below-average bottom-line performance with a current EPS of 0.09.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.01, ReposiTrak adopts a prudent financial strategy, indicating a balanced approach to debt management.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 75.73, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 20.72 is above industry norms, reflecting an elevated valuation for ReposiTrak's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 49.19, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Essential Transaction Codes Unveiled</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000050471">Check Out The Full List Of ReposiTrak's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TRAK

Sell Alert: Randall K Fields Cashes Out $165K In ReposiTrak Stock

It was reported on December 26, that John Cattonar, EVP &amp; Chief Investment Officer at SITE Centers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SITC#NYSE">SITC</a>) executed a significant insider sell, according to an SEC filing.
What Happened: After conducting a thorough analysis, Cattonar sold 8,794 shares of SITE Centers. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000894315/000095017024140396//Archives/edgar/data/894315/000095017024140396/0000950170-24-140396-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total transaction value is $133,823.
In the Friday's morning session, SITE Centers's shares are currently trading at $15.31, experiencing a down of 0.0%.
<h3>Delving into SITE Centers's Background</h3>
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.
<h3>Key Indicators: SITE Centers's Financial Health</h3>
Revenue Growth: SITE Centers's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -37.3%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 68.76%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 6.09, SITE Centers showcases strong earnings per share.
</li>
</ul>
Debt Management: SITE Centers's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.12.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 1.12 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.77, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 0.22, SITE Centers could be considered undervalued.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
Emphasizing the importance of a comprehensive approach, considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000894315">Check Out The Full List Of SITE Centers's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SITC

SITE Centers EVP & Chief Investment Officer Trades $133K In Company Stock

The Glimpse Group Shares Halted On Circuit Breaker To The Upside; Stock Now Up 13.9%

On December 26, Herman Bulls, Board Member at Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) executed a significant insider buy, as disclosed in the latest SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001868941/000186894124000095//Archives/edgar/data/1868941/000186894124000095/0001868941-24-000095-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Bulls purchased 10,000 shares of Fluence Energy. The total transaction amounted to $155,680. 
The latest update on Friday morning shows Fluence Energy shares up by 4.05%, trading at $16.44.
<h3>All You Need to Know About Fluence Energy</h3>
Fluence Energy Inc is enabling the global clean energy transition with market-leading energy storage products and services, and digital applications for renewables and storage. Geographically, it derives a majority of its revenue from the Americas.
<h3>Fluence Energy's Financial Performance</h3>
Revenue Growth: Fluence Energy's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 82.49%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 12.82%, indicating concerns regarding cost management and overall profitability relative to its industry counterparts.
</li>
<li>
Earnings per Share (EPS): Fluence Energy's EPS lags behind the industry average, indicating concerns and potential challenges with a current EPS of 0.37.
</li>
</ul>
Debt Management: Fluence Energy's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.06.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: Fluence Energy's current Price to Earnings (P/E) ratio of 121.54 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 1.08, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 39.65, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001868941">Check Out The Full List Of Fluence Energy's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FLNC

Eye On Growth: Herman Bulls Adds $155K Of Fluence Energy Stock To Portfolio

A significant insider buy by Eugene David Maher, President and CEO at Acushnet Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLF#NYSE">GOLF</a>), was executed on December 26, and reported in the recent SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001672013/000112760224030045//Archives/edgar/data/1672013/000112760224030045/0001127602-24-030045-index.htm">U.S. Securities and Exchange Commission</a> on Thursday unveiled that Maher made a notable purchase of 2,230 shares of Acushnet Hldgs, valuing at $155,921.
Tracking the Friday's morning session, Acushnet Hldgs shares are trading at $71.9, showing a up of 0.57%.
<h3>Discovering Acushnet Hldgs: A Closer Look</h3>
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, of which key revenue is derived from the sales of golf balls and golf gloves. The operating segments of the company are Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear. Geographically, the company operates in the United States, EMEA, Japan, Korea and other countries, of which a majority of the revenue is generated from the operations in the United States.
<h3>Understanding the Numbers: Acushnet Hldgs's Finances</h3>
Positive Revenue Trend: Examining Acushnet Hldgs's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.57% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 54.37%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): Acushnet Hldgs's EPS is a standout, portraying a positive bottom-line trend that exceeds the industry average with a current EPS of 0.89.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.85, caution is advised due to increased financial risk.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 23.83 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 1.9 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 14.66, Acushnet Hldgs demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>A Closer Look at Important Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001672013">Check Out The Full List Of Acushnet Hldgs's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GOLF

Acushnet Hldgs President and CEO Trades $155K In Company Stock

Disclosed on December 26, Bradley Herring, Chief Financial Officer at Enfusion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENFN#NYSE">ENFN</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: Herring's decision to sell 24,443 shares of Enfusion was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001868912/000110465924131717//Archives/edgar/data/1868912/000110465924131717/0001104659-24-131717-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total value of the sale is $259,340.
As of Friday morning, Enfusion shares are down by 0.0%, currently priced at $10.69.
<h3>All You Need to Know About Enfusion</h3>
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.
<h3>Enfusion: Delving into Financials</h3>
Revenue Growth: Over the 3 months period, Enfusion showcased positive performance, achieving a revenue growth rate of 15.35% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: Achieving a high gross margin of 68.06%, the company performs well in terms of cost management and profitability within its sector.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Enfusion exhibits below-average bottom-line performance with a current EPS of 0.02.
</li>
</ul>
Debt Management: Enfusion's debt-to-equity ratio is below the industry average at 0.3, reflecting a lower dependency on debt financing and a more conservative financial approach.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: Enfusion's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 267.25.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 7.05 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Enfusion's EV/EBITDA ratio of 52.42 exceeds industry averages, indicating a premium valuation in the market
</li>
</ul>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001868912">Check Out The Full List Of Enfusion's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ENFN

Sell Alert: Bradley Herring Cashes Out $259K In Enfusion Stock

Cannara Biotech, Inc. (TSE:LOVE) has released an update. Cannara Biotech Inc. has reported a significant increase in financial results for Q2 2024,...

Cannara Biotech Boasts Strong Q2 Growth

Cannara Biotech reports Q2 results

Cannara Biotech (TSE:LOVE) has released an update. Cannara Biotech Inc. has reported a significant increase in net revenues to $19.5 million for Q3...

Cannara Biotech's Revenue Soars in Q3 2024

Cannara Biotech GAAP EPS of C$0.02, revenue of C$19.5M

Cannara Biotech (TSE:LOVE) has released an update. Cannara Biotech Inc. has reached a new pinnacle by achieving a record national market share of 3...

Cannara Biotech Hits Record Market Share in July

Reports Q4 revenue C$23.4M vs. C$18.3M last year. "Fiscal 2024 was a transformative year for Cannara, showcasing the resilience of our business mod...

Cannara Biotech reports Q4 EPS C$0.06 vs. C$0.05 last year

Cannara Biotech (TSE:LOVE) has released an update. Cannara Biotech Inc. has reported record-breaking sales growth and operating cash flow for fisca...

Cannara Biotech Reports Record Growth in 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Macy's (M) delayed its Q3 earnings rel...

Macy's uncovers employee fraud, Summit to be acquired: Morning Buzz

Cannara Biotech (TSE:LOVE) has released an update. Cannara Biotech is set to engage investors with a webcast presentation on December 19, 2024, whe...

Cannara Biotech Hosts Investor Webcast in December

AAPL

BBIO

BBWI

BHVN

CMCSA

CRGO

ENLC

FIVE

GASS

HOOD

INTC

KODK

LOVFF

MSFT

PARA

PARAA

RIVN

SNOW

SRPT

SRRK

TSLA

Earnings

Small Cap

Press Releases

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion

Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export Sale

Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans

Cannara Biotech Reports Q2 2024 Financial Results

Cannara Biotech Reports Q3 2024 Financial Results

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

TSXV:LOVE

Cannara Biotech

Comments

Cannara Biotech

Intérêt court

Cannara Biotech (OTC:LOVFF) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL